AmpliPhi Biosciences is Biotechnology in United States that focus on Armata Pharmaceuticals Inc business. Founded in 1989. They cover business area such as Armata Pharmaceuticals Inc, human health, novel natural and synthetic bacteriophage-base therapy, multidrug-resistant bacterial infection, preventable infectious disease, its product candidate, Staphylococcus aureus, multidrug-resistant strain.
1989
( 35 years old in 2024 )
Armata Pharmaceuticals Inc
-
3579 Valley Centre Drive
Suite 100
San Diego, CA 92130
United States
Private
Armata Pharmaceuticals Inchuman healthnovel natural and synthetic bacteriophage-base therapymultidrug-resistant bacterial infectionpreventable infectious diseaseits product candidateStaphylococcus aureusmultidrug-resistant strain
* We use standard office opening hours in near AmpliPhi Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AmpliPhi Biosciences is Biotechnology business from United States that founded in 1989 (35 years old in 2024), AmpliPhi Biosciences business is focusing on Armata Pharmaceuticals Inc.
AmpliPhi Biosciences headquarter office and corporate office address is located in 3579 Valley Centre Drive Suite 100 San Diego, CA 92130 United States.
AmpliPhi Biosciences was founded in United States.
In 2024, AmpliPhi Biosciences is currently focus on Armata Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Armata Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AmpliPhi Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.